^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Ewing Sarcoma |
| Drug: | cyclophosphamide (Alkylating agent) + topotecan (Topoisomerase I inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
11/20/2020
Excerpt:
Ewing sarcoma: Second-line therapy (relapsed/refractory or metastatic disease)…Preferred Regimens…Cyclophosphamide and topotecan
